Ignite Creation Date:
2024-05-06 @ 3:29 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04645979
Status:
COMPLETED
Last Update Posted:
2023-06-01
First Post:
2020-11-23
Brief Title:
A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis Also Known as Hay Fever in Mexico
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
The Perception of Celestamine Treatment in Mexico a Retrospective Assessment of Consumer Perception of Prior Celestamine Use
Status:
COMPLETED
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Acute allergic rhinitis is a common allergic reaction to things like pollen or dust It causes inflammation inside the nose resulting in symptoms similar to the common cold Allergic rhinitis is also known as hay fever
In this study the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months During the study participants will complete an online questionnaire about their experience with betamethasone plus loratadine
In this study the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months During the study participants will complete an online questionnaire about their experience with betamethasone plus loratadine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None